MiR-21 is an oncomiR whose overexpression promotes cancer progression by suppressing tumour-suppressor genes such as PTEN, PDCD4, and RECK, leading to increased proliferation, invasiveness, and resistance to apoptosis [53]. This evidence concerns the gene RECK and cancer.